董森林,王艳青

• 1:山西医科大学第二医院皮肤科

摘要(Abstract)：

淋球菌极易产生耐药,探讨淋球菌耐药机制是目前的研究热点。本文主要阐述淋球菌的多种耐药分子机制,包括淋球菌对之前治疗用药如磺胺类、青霉素、四环素及喹诺酮类等的耐药机制,以及对目前一线用药头孢曲松产生耐药的分子机制,最后阐述了淋球菌的耐药监测及淋病治疗情况。

关键词(KeyWords)： 淋球菌;耐药机制;监测;治疗

Abstract:

Keywords:

基金项目(Foundation): 山西省卫生和计划生育委员会科研课题(2017061)~~

作者(Author): 董森林,王艳青

DOI: 10.13419/j.cnki.aids.2020.05.33

参考文献(References)：

• [1]疾病预防控制局．2017年全国法定传染病疫情概况[EB/OL].(2018)[2019-03-10].http://www.nhc.gov.cn/jkj/s3578/201802/de926bdb046749abb7b0a8e23d929104.shtml.
• [2]疾病预防控制局．2016年全国法定传染病疫情概况[EB/OL].(2017)[2019-03-10].http://www.nhc.gov.cn/jkj/s6873/201702/38ca5990f8a54ddf9ca6308f ec406157.shtml.
• [3]Unemo M,Shafer WM.Antimicrobial Resistance in Neisseria gonorrhoeae in the21st Century:Past,Evolution,and Future[J].Clinical Microbiology Reviews,2014,27(3):587.
• [4]Ohnishi M,Saika T,Hoshina S,et al.Ceftriaxone-resistant Neisseria gonorrhoeae,Japan[J].Emerging Infectious Diseases,2011,17(1):148-149.
• [5]Unemo M,Golparian D,Nicholas R,et al.High-level cefixime-and ceftriaxoneresistant Neisseria gonorrhoeae in France:novel pen A mosaic allele in a successful international clone causes treatment failure[J].Antimicrob Agents Chemother,2012,56(3):1273-1280.
• [6]Zhao L,Liu A,Li R,et al.Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong,China,2007 to 2014[J].International Journal of Antimicrobial Agents,2017,51(1):52-56.
• [7]杨波,胡丽华,赵建妹.德清地区2013-2016年淋球菌耐药监测结果分析[J].中国公共卫生管理,2018,34(4):497-499.
• [8]Louren?o APRDC,Santos KTBD,Moreira BM,et al.Antimicrobial resistance in Neisseria gonorrhoeae:history,molecular mechanisms and epidemiological aspects of an emerging global threat[J].Brazilian Journal of Microbiology,2017,48(4):617-628.
• [9]Phillips I.β-Lactaniase-producing,penicillin-resistant gonococcus[J].Lancet,1976:656-657.[Epub ahead of print].
• [10]Unemo M,Shafer WM.Antibiotic resistance in Neisseria gonorrhoeae:origin,evolution,and lessons learned for the future[J].Annals of the New York Academy of Sciences,2015,1230(1):E19-E28.
• [11]Belland RJ,Morrison SG,Ison C,et al.Neisseria gonorrhoeae acquires mutations in analogous regions of gyr A and par C in fluoroquinolone‐resistant isolates[J].Molecular microbiology,2010,14(2):371-380.
• [12]Unemo M,Nicholas R.Emergence of multidrug-resistant,extensively drugresistant and untreatable gonorrhea[J].Future Microbiol,2012,7(12):1401-1422.
• [13]Ohnishi M,Golparian D,Shimuta K,et al.Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?:detailed characterization of the first strain with high-level resistance to ceftriaxone[J].Antimicrobial agents and chemotherapy,2011,55(7):3538-3545.
• [14]C?m J,Serra J,Ayats J,et al.Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia,Spain[J].J Antimicrob Chemother,2012,67(8):1858-1860.
• [15]Trembizki E,Wand H,Donovan B,et al.The Molecular Epidemiology and Antimicrobial Resistance of Neisseria gonorrhoeae in Australia:A Nationwide Cross-Sectional Study,2012[J].Clin Infect Dis,2016,63(12):1591-1598.
• [16]Lee R,Seemann T,Heffernan H,et al.Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand[J].J Antimicrob Chemother,2018,73(2):353-564.
• [17]Peng T,Lin H,Liu Q,et al.Ceftriaxone susceptibility and molecular characteristics of Neisseria gonorrhoeae isolates in Changsha,China[J].Journal of Infection&Chemotherapy Official Journal of the Japan Society of Chemotherapy,2017,23(6):385-389.
• [18]Lewis D.Global resistance of Neisseria gonorrhoeae:when theory becomes reality[J].Curr Opin Infect Dis,2014,27(1):62-67.
• [19]Serra-Pladevall J,BarberáM,Rodriguez S,et al.Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona:pen A,pon A,mtr R,and por B mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins[J].Eur J Clin Microbiol Infect Dis,2016,35(9):1549-1556.
• [20]DonàV,Low N,Golparian D,et al.Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae[J].Expert Rev Mol Diagn,2017,17(9):845-859.
• [21]Unemo M,Del Rio C,Shafer W.Antimicrobial Resistance Expressed by Neisseria gonorrhoeae:A Major Global Public Health Problem in the 21st Century[J].Microbiol Spectr,2016,4(3):El10-0009-2015.
• [22]Unemo M.Current and future antimicrobial treatment of gonorrhoea-the rapidly evolving Neisseria gonorrhoeae continues to challenge[J].BMC Infect Dis,2015,15(1):364
• [23]Barbee LA,Dombrowski JC.Control of Neisseria gonorrhoeae in the era of evolving antimicrobial resistance[J].Infectious Disease Clinics of North America,2013,27(4):723-737.
• [24]Weston E,Wi T,Papp J.Strengthening Global Surveillance for Antimicrobial Drug-Resistant Neisseria gonorrhoeae through the Enhanced Gonococcal Antimicrobial Surveillance Program[J].Emerging Infect Dis,2017,23(13):S47-S52.
• [25]尹跃平,陈绍椿,韩燕,等.中国淋球菌耐药监测现状及展望[J].中华皮肤科杂志,2018,51(5):325-327.
• [26]Phillips LT,Witney A,Izquierdocarrasco F,et al.P1.32 Hand-held rapid whole genome nanopore sequencing to predict neisseria gonorrhoeae antibiotic susceptibility:steps towards clinic based tailored antimicrobial therapy[C].STIand HIV World,Congress Abstracts,July 9-12,Rio de Janeiro,Brazil,2017.
• [27]Mortimer T,Grad Y.Applications of genomics to slow the spread of multidrugresistant Neisseria gonorrhoeae[J].Ann N Y Acad Sci,2019,1435(1):93-109.
• [28]Harrison OB,Clemence M,Dillard JP,et al.Genomic analyses of Neisseria gonorrhoeae reveal an association of the gonococcal genetic island with antimicrobial resistance[J].Journal of Infection,2016,73(6):578-587.
• [29]De SD,Peters J,Cole K,et al.Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae:an observational study[J].Lancet Infectious Diseases,2016,16(11):1295-1303.
• [30]Suay-García B,Pérez-Gracia M.Drug-resistant Neisseria gonorrhoeae:latest developments[J].Eur J Clin Microbiol Infect Dis,2017,36(7):1065-1071.
• [31]Wi T,Lahra M,Ndowa F,et al.Antimicrobial resistance in Neisseria gonorrhoeae:Global surveillance and a call for international collaborative action[J].PLo S Med,2017,14(7):e1002344.
• [32]Kirkcaldy RD.S08.1 Treatment of Gonorrhoea in an Era of Emerging Cephalosporin Resistance and Results of a Randomised Trial of New Potential Treatment Options[J].Sexually Transmitted Infections,2013,89(Suppl 1):A14-A15.